Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake

Area of Science:

• Neurogenetics
• Molecular Neuroscience

Background:

• Episodic ataxia (EA) is a group of neurological disorders characterized by recurrent episodes of ataxia.
• Several genes are implicated in EA, with mutations in CACNA1A causing EA2.
• Recent research identified SLC1A3 mutations in a severe form of EA (EA6), affecting the glutamate transporter EAAT1.

Observation:

• This study investigated the role of the SLC1A3 gene in patients with EA who tested negative for CACNA1A mutations.
• Genetic analysis of 20 EA patients revealed one novel mutation in the SLC1A3 gene.
• Functional studies assessed the impact of the identified mutation on EAAT1 glutamate transporter activity.

Findings:

• A novel missense mutation (C186S) in SLC1A3 was identified, segregating with EA in three family members.
• The mutant EAAT1 protein exhibited a modest but significant reduction in glutamate uptake capacity.
• The identified mutation was associated with milder EA symptoms, lacking seizures or alternating hemiplegia.

Implications:

• This research expands the known clinical spectrum of SLC1A3-related disorders to include milder forms of episodic ataxia.
• The findings suggest a correlation between the degree of glutamate transporter dysfunction and the severity of EA6 symptoms.
• Understanding the genotype-phenotype relationship in EA6 can aid in diagnosis and management.